Antioxidant therapy, N-acetyl-L-cysteine, effects on pancreatic β cells: therapeutic promise or potential harm?
Endocrinology · 29.09.2026 · 167 (11)
DOI: 10.1210/endocr/bqag114 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology, online erschienen am 10.10.2026. Verfasst von Meg Schuurman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Children's Health Research Institute, University of Western Ontario, London, ON N6C 2V5, Canada. Hauptthemen laut MEDLINE: Acetylcysteine, Insulin-Secreting Cells, Antioxidants. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institute of Health Research.
Abstract (Originalsprache)
N-acetyl-L-cysteine (NAC) is a widely used antioxidant with increasing public interest in its use for treating metabolic disease, yet its effects on pancreatic β cells remain incompletely understood. Most studies focus on NAC's benefits under pathological conditions—such as obesity, high-fat diet exposure, and type 2 diabetes—where oxidative stress impairs β-cell function, identity, and survival. In these contexts, NAC can reduce oxidative damage, preserve insulin secretion, and limit islet fibrosis. However, far fewer studies examine NAC under normal physiological or aging conditions, where moderate reactive oxygen species levels are required for β-cell signaling and glucose-stimulated insulin secretion. Emerging evidence shows that excessive antioxidant exposure during non-pathological states may disrupt redox-dependent pathways, suppress insulin biosynthesis and exocytosis, and contribute to reductive stress. Here, we review the current evidence of NAC's impact on β cells across physiological, aging, and pathological settings. Moreover, we highlight that NAC can be protective or detrimental depending on redox state, metabolic environment, and dosing, which emphasizes the need for careful consideration of antioxidant use in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Health Research Institute, University of Western Ontario, London, ON N6C 2V5, Canada.
- Department of Physiology & Pharmacology, University of Western Ontario, London, ON N6A 5C1, Canada.
- Department of Medicine, University of Western Ontario, London, ON N6A 5C1, Canada.
ORCID-Profile: Malina Barillaro, Rennian Wang
Förderung
- Canadian Institute of Health Research
Zitieren
APA
Schuurman, M., Nguyen, J., Barillaro, M., Borradaile, N., & Wang, R. (2026). Antioxidant therapy, N-acetyl-L-cysteine, effects on pancreatic β cells: therapeutic promise or potential harm?. Endocrinology, 167(11). https://doi.org/10.1210/endocr/bqag114
Vancouver
Schuurman M, Nguyen J, Barillaro M, Borradaile N, Wang R. Antioxidant therapy, N-acetyl-L-cysteine, effects on pancreatic β cells: therapeutic promise or potential harm?. Endocrinology. 2026;167(11). doi:10.1210/endocr/bqag114
BibTeX
@article{Schuurman2026,
author = {Schuurman, Meg and Nguyen, Jonathan and Barillaro, Malina and Borradaile, Nica and Wang, Rennian},
title = {Antioxidant therapy, N-acetyl-L-cysteine, effects on pancreatic β cells: therapeutic promise or potential harm?},
journal = {Endocrinology},
year = {2026},
volume = {167},
number = {11},
doi = {10.1210/endocr/bqag114}
}
EUVIMED